500
Views
15
CrossRef citations to date
0
Altmetric
Original

A phase I study to study arsenic trioxide with radiation and hyperthermia in advanced head and neck cancer

, MD, DGO
Pages 391-397 | Received 14 Dec 2005, Accepted 28 Mar 2006, Published online: 09 Jul 2009

References

  • Forastier A, Koch W, Trotti A. Head and neck cancer. N Engl J Med 2001; 345: 1890–1900
  • Pignon JP, Bowrhis J, Domenge C. Chemotherapy added to loco-regional treatment for head and neck squamous cell carcinoma. Meta-analysis of chemotherapy on head & neck cancer Lancet 2000; 355: 949–955
  • Valdagni R, Amichetti M, Pani G. Radical radiation alone versus radical radiation plus microwave hyperthermia for N3 (TNM-UICC) neck nodes: A prospective randomized clinical trial. Int J Radiat Oncol Biol Phys 1988; 15: 13–24
  • Griffin RJ, Lee SH, Rood KL, Stewart MJ, Lyons JC, Lew YS, Park H, Song CW, Robert J. Use of arsenic trioxide as an anti-vascular and thermosensitizing agent in solid tumours. Neoplasia 2002; 2: 555–560
  • Lew YS, Brown SL, Griffin RJ, Song CW, Kim JH. Arsenic trioxide causes selective necrosis in solid murine tumours by vascular shutdown. Cancer Resh 1999; 59: 6033–6037
  • Chen G-Q, Shi X-G, Tang W. Use of arsenic trioxide in the treatment of acute pro-myelocytic leukemia. As2O3 exerts dose dependent dual effects on APL cells. Blood 1997; 89: 3345–3353
  • Gibbs IC, Harsh G, Tupper L, Recht L, Knox SJ. Phase I trial of arsenic trioxide and fractionated stereotactic radiation for recurrent malignant glioma. Int J Radiat Oncol Biol Phys 2005; 63(suppl), Abstract 1021
  • Gallagher R, Ferrari A, Makower D. Pilot results from a phase II trial of arsenic trioxide in hormone-refractory prostrate cancer. Cancer Invest 2002; 20: 84–85, Abstract 50
  • Kucky J, Yu R, Schwartz L. Phase II trial of arsenic trioxide in patients with metastatic renal cell carcinoma. Invest New Drugs 2002; 20: 327–330
  • Zhang T, Wang SS, Hong L, Wang XL, Qi QH. Arsenic trioxide induces apoptosis in rat hepatocellular carcinoma cells in vivo. J Exp Clin Cancer Res 2003; 22: 61–68
  • Miller WH, Jr, Schipper HM, Lee SH, Singer J, Waxman S. Mechanism of action of arsenic trioxide. Cancer Res 2002; 62: 3893–3903
  • Griffin RJ, Monzen H, Williams BW, Park H, Lee SH, Song CW. Arsenic trioxide induce selective tumour vascular damage via oxidative stress and increases thermosensitivity of tumours. Int J Hyperthermia 2003; 19: 575–589
  • Song CW. Effect of local hyperthermia on blood flow and microenvironment a review. Cancer Res 1984; 44: 4721–4730
  • Kim JH, Lew YS, Ryu S, Brown SL. Arsenic trioxide enhances radiation response of glioma in the rat brain. Radiat Res 2003; 160: 662–666
  • Van der Zee J, Gonzalez D, Van Rhoon GC, Van Dijk JD, Van Putten WL, Hart AA. Comparison of radiotherapy alone with radiotherapy plus hyperthermia in locally advanced pelvic tumours: A prospective randomized, multicentric trial. Lancet 2000; 355: 1119–1125
  • Grant MF, Tumer EM, Alexndar HR, Jr. Effects of hyperthermia and tumour necrosis factor on inflammatory cytokine secretion & pro-coagulant activity in endothelial cells. Cytokine 2000; 12: 339–347

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.